Tokyo, Sept. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062840) titled 'A study of adherence to skincare using medicated cosmetics and quality of life in patients with cancer' on Sept. 7.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Hyogo Cancer Center

Condition: Condition - Skin concerns such as xerosis, hyperpigmentation, and wrinkles in patients with cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To evaluate 12-week adherence to a skincare regimen using medicated cosmetic products in patients with cancer compared with noncancer controls, and to assess changes in skin findings and quality of life during the intervention. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Participants use Collage Repair Lotion R and Collage Repair Bright Essence DR for 12 weeks. In principle, participants replace the lotion and serum used before enrollment with the study products and apply them twice daily, in the morning and evening, at home. Other products used before study entry, including makeup remover, facial cleanser, sunscreen, and emulsion or moisturizer, may be continued. The same intervention is provided to participants with cancer and noncancer controls.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1,Participants aged 18 years or older at the time of informed consent. 2,Cancer group: outpatients with cancer who have skin concerns such as xerosis, hyperpigmentation, or wrinkles that do not require dermatologic treatment. Both patients with active cancer and those who have completed cancer treatment are eligible. 3,Noncancer control group: healthy individuals who do not meet the cancer-specific criterion described above. 4,Participants who receive an explanation of the study and provide informed consent. Key exclusion criteria - 1,Participants with severe skin disease. 2,Participants with a history of contact dermatitis or similar skin reactions caused by a study product or a product containing similar ingredients. 3,Participants who are expected to have difficulty attending the end-of-study assessment. 4,Participants considered unsuitable for study participation by the investigator. Target Size - 80

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2024 Year 05 Month 23 Day Date of IRB - 2024 Year 07 Month 30 Day Anticipated trial start date - 2024 Year 10 Month 07 Day Last follow-up date - 2026 Year 01 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071936

Disclaimer: Curated by HT Syndication.